FGFR Inhibitor Debio 1347

An orally bioavailable inhibitor of the fibroblast growth factor receptor subtypes 1 (FGFR-1), 2 (FGFR-2) and 3 (FGFR-3), with potential antineoplastic activity. FGFR inhibitor debio 1347 binds to and inhibits FGFR-1, -2, and -3, which result in the inhibition of FGFR-mediated signal transduction pathways. This leads to the inhibition of both tumor cell proliferation and angiogenesis, and causes cell death in FGFR-overexpressing tumor cells. FGFR, a family of receptor tyrosine kinases upregulated in many tumor cell types, is essential for tumor cellular proliferation, differentiation and survival. (NCI Thesaurus)

YOU MAY ALSO LIKE

FGFR Inhibitor AZD4547

An orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor AZD4547 binds to and inhibits…

FGF9 wt Allele

Human FGF9 wild-type allele is located within 13q11-q12 and is approximately 30 kb in length. This allele, which encodes glia-activating factor protein,…

FGF9 Gene

This gene plays a role in the promotion of cellular growth/proliferation and negative regulation of apoptosis. It is also involved in glial…

FGF8 wt Allele

Human FGF8 wild-type allele is located within 10q24 and is approximately 6 kb in length. This allele, which encodes fibroblast growth factor…

FGF8 Gene

This gene is involved in development and organogenesis.

FGF7 wt Allele

Human FGF7 wild-type allele is located within 15q15-q21.1 and is approximately 64 kb in length. This allele, which encodes keratinocyte growth factor…